BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Telemedicine Cart Market: Top 3 trends driving the industry expansion through 2026

  The telemedicine cart market is expected to capture prominent growth given to rapid technological developments in telemedicine services.

  February 8, 2021

   · 

  3 min read
• Vascular Graft Market: Top 6 trends driving the global industry expansion through 2024

  The global vascular graft market is poised to gain major impetus over the ensuing years from increasing number of hemodialysis procedures and cardiac surgeries across the globe.

  February 8, 2021

   · 

  4 min read
• Relay Medical Provides Update on Operations and Corporate Activity

  Relay Medical is pleased to announce the appointment of Ian Fine as Vice-President of R&D of Relay Medical and Chief Technology Officer of Fionet Rapid Response Group.

  February 8, 2021

   · 

  5 min read
• UKONIQ™ (umbralisib) Now Approved by the FDA; Onco360® Selected as Exclusive Specialty Pharmacy Partner

  Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by TG Therapeutics, Inc. to be the exclusive specialty pharmacy partner for UKONIQTM (umbralisib),

  February 8, 2021

   · 

  3 min read
• Pharm Country

  MTF Biologics’ Awarded Premier Regenerative Skin Agreement for Wound Care Innovations with Premier

  MTF Biologics has been awarded a group purchasing agreement for Regenerative Skin Tissues with Premier.

  February 8, 2021

   · 

  2 min read
• FDA

  ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from U.S. FDA for IM156 in Ideopathic Pulmonary Fibrosis and Completes Financing

  - Phase 1 clinical study recruitment in healthy volunteers is expected to start in Q1 2021 - - Pre-clinical studies have demonstrated a strong anti-fibrotic effect in animal models of fibrosis - - Recently completed Phase 1 trial in oncology patients demonstrated good safety profile -

  February 8, 2021

   · 

  3 min read
• Business

  EPIC Pharmacies Announces CEO Departure Effective March

  After more than six years of service, Jay Romero will step down in his role as CEO of EPIC Pharmacies, Inc., a national network of independently owned pharmacies, and president of EPIC Pharmacy Network, Inc., a nationwide Pharmacy Services Administration Organization, effective March 1, 2021.

  February 8, 2021

   · 

  2 min read
• Deals

  Luminex Corporation Declares First Quarter Cash Dividend

  Luminex Corporation (Nasdaq:LMNX) (the “Company”) today announced that its board of directors declared a cash dividend for the first quarter of 2021 of $0.10 per share of common stock payable on April 15 , 2021 to stockholders of record as of the close of business March 25, 2021 .

  February 8, 2021

   · 

  1 min read
• Pharm Country

  Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021

  Initial Data Suggest Early Signs of Disease Stabilization in Children with Fatal Neurologic Disease Plan to Submit IND for Next Clinical Study in 2H2021

  February 8, 2021

   · 

  7 min read
• Business

  Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients

  Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application

  February 8, 2021

   · 

  4 min read